Update of recent studies in chronic myeloid leukemia

被引:0
|
作者
Karen Seiter
机构
[1] New York Medical College,Division of Hematology and Oncology
关键词
Imatinib; Chronic Myeloid Leukemia; Dasatinib; Nilotinib; Event Free Survival;
D O I
10.1186/1756-8722-2-S1-A2
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Update in Childhood Chronic Myeloid Leukemia
    Giona, Fiorina
    Bianchi, Simona
    HEMATO, 2022, 3 (04): : 718 - 730
  • [2] CHRONIC MYELOID-LEUKEMIA - AN UPDATE
    TURA, S
    ACTA HAEMATOLOGICA, 1987, 78 : 203 - 203
  • [3] Chronic myeloid leukemia - update 2020
    Heim, Dominik
    Ebnoether, Monika
    Favre, Genevieve
    THERAPEUTISCHE UMSCHAU, 2019, 76 (09) : 503 - 509
  • [4] Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia
    Musumeci, Francesca
    Greco, Chiara
    Grossi, Giancarlo
    Molinari, Alessio
    Schenone, Silvia
    CANCERS, 2018, 10 (11)
  • [5] Chronic Myeloid Leukemia: An Update with Indian Experience
    Gupta, Sudeep
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (03) : 45 - 45
  • [6] Update on emerging treatments for chronic myeloid leukemia
    Fava, Carmen
    Morotti, Alessandro
    Dogliotti, Irene
    Saglio, Giuseppe
    Rege-Cambrin, Giovanna
    EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (02) : 183 - 196
  • [7] CHRONIC MYELOID-LEUKEMIA TRIAL UPDATE
    BRACKENRIDGE, I
    JOURNAL OF MEDICAL GENETICS, 1989, 26 (04) : 286 - 286
  • [8] Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia
    Dao, Kim-Hien T.
    Tyner, Jeffrey W.
    Gotlib, Jason
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (05) : 432 - 441
  • [9] Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia
    Kim-Hien T. Dao
    Jeffrey W. Tyner
    Jason Gotlib
    Current Hematologic Malignancy Reports, 2017, 12 : 432 - 441
  • [10] An Update on the Management of Advanced Phase Chronic Myeloid Leukemia
    Short, Nicholas J.
    Senapati, Jayastu
    Jabbour, Elias
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (6) : 234 - 242